PetMed Express, Inc. PETS
Set alert
1.19 USD +0.01 +0.85%
At close · Oct 30
1.18 -0.01 -0.58%
After hours · Oct 30, 4:00 PM ET
1.17 Day range 1.20
1.15 52-week range 3.90
- YTD
- -62.81%
- 1 year
- -52.78%
- Open
- 1.17
- Prev close
- 1.18
- Mkt cap
- 25.80M
- Vol
- 42.35K
- Avg vol
- 110.68K
- EPS
- -1.38
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.17
- High
- 1.20
- Forward P/E
- -161.67
- Beta
- 0.68
- Short ratio
- 3.46
- Inst. own
- 47.79%
- Dividend
- 0.00
- Ex-div date
- Aug 10, 2023
- 50-d avg
- 4.77
- 200-d avg
- 4.19
- 1y target
- 3.75
2Y chart
Events in this range
- Nov 6, 2024Earnings: 0.11; estimate -0.06; surprise 283.33%
Signals (74)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 26, 2026 | 6 days ago |
| MACD: Buy Signal | Oct 21, 2026 | 1 week ago |
| RSI: Oversold | Sep 22, 2026 | 1 month ago |
| RSI: Oversold | Sep 16, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 9, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 28, 2026 | 2 months ago |
| SMA: Bearish | Aug 14, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 14, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 13, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 31, 2026 | 3 months ago |
| SMA: Bullish | Jul 23, 2026 | 3 months ago |
| SMA: Bearish | Jul 22, 2026 | 3 months ago |
| SMA: Bullish | Jul 21, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 22, 2026 | 4 months ago |
| RSI: Oversold | Jun 3, 2026 | 5 months ago |
| MACD: Sell Signal | May 21, 2026 | 5 months ago |
| MACD: Buy Signal | Apr 1, 2026 | 7 months ago |
| RSI: Oversold | Mar 27, 2026 | 7 months ago |
| RSI: Oversold | Mar 23, 2026 | 7 months ago |
| RSI: Oversold | Mar 11, 2026 | 7 months ago |
| SMA: Bearish | Feb 19, 2026 | 8 months ago |
| SMA: Bearish | Feb 17, 2026 | 8 months ago |
| SMA: Bullish | Feb 13, 2026 | 8 months ago |
| SMA: Bullish | Feb 13, 2026 | 8 months ago |
| SMA: Bearish | Feb 6, 2026 | 8 months ago |
| SMA: Bearish | Feb 5, 2026 | 8 months ago |
| MACD: Sell Signal | Jan 2, 2026 | 10 months ago |
| SMA: Bullish | Dec 16, 2025 | 10 months ago |
| RSI: Overbought | Dec 16, 2025 | 10 months ago |
| SMA: Bullish | Dec 11, 2025 | 10 months ago |
| RSI: Overbought | Dec 11, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 4, 2025 | 11 months ago |
| RSI: Oversold | Nov 19, 2025 | 11 months ago |
| SMA: Bearish | Nov 13, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 13, 2025 | 11 months ago |
| SMA: Bullish | Nov 11, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 10, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 3, 2025 | 12 months ago |
| SMA: Bearish | Oct 23, 2025 | 1 year ago |
| SMA: Bullish | Oct 22, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 3, 2025 | 1 year ago |
| RSI: Oversold | Sep 29, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 8, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 21, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 31, 2025 | 1 year ago |
| SMA: Bearish | Jul 28, 2025 | 1 year ago |
| SMA: Bullish | Jul 23, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 21, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 15, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 8, 2025 | 1 year ago |
| SMA: Bearish | Jun 17, 2025 | 1 year ago |
| SMA: Bullish | Jun 16, 2025 | 1 year ago |
| SMA: Bearish | Jun 13, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 12, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 3, 2025 | 1 year ago |
| MACD: Sell Signal | May 30, 2025 | 1 year ago |
| SMA: Bullish | May 27, 2025 | 1 year ago |
| SMA: Bearish | May 23, 2025 | 1 year ago |
| SMA: Bullish | May 12, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 23, 2025 | 1 year ago |
| RSI: Oversold | Apr 4, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 3, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 17, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 12, 2025 | 1 year ago |
| SMA: Bearish | Feb 11, 2025 | 1 year ago |
| SMA: Bullish | Feb 5, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 5, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 31, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 30, 2025 | 1 year ago |
| MACD: Sell Signal | Jan 27, 2025 | 1 year ago |
| SMA: Bearish | Jan 22, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 16, 2025 | 1 year ago |
| SMA: Bullish | Jan 15, 2025 | 1 year ago |
| RSI: Overbought | Dec 6, 2024 | 1 year ago |
Key statistics
- Market cap
- 100.22M
- Enterprise value
- 51.73M
- Trailing P/E
- 0.00
- Forward P/E
- -161.67
- PEG ratio
- 0.00
- Price / sales
- 0.39
- Price / book
- 1.04
- EPS (TTM)
- -0.06
- Beta
- 0.68
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -0.37%
- Revenue (TTM)
- 259.34M
- Revenue growth
- -16.10%
- Free cash flow
- 20.24M
- Total cash
- 52.05M
- Total debt
- 1.21M
- Return on equity
- -0.92%
- Shares outstanding
- 20.66M
- Short % of float
- 5.71%
- 50-day average
- 4.77
- 200-day average
- 4.19
Analyst view
Consensus: none
Price target (mean) 3.75 +215.1% upside
Now 1.19
- Target (low)
- 3.50
- Target (mean)
- 3.75
- Target (high)
- 4.00
Ratings (0m) 2 0 buy · 1 hold · 1 sell
- Strong buy0
- Buy0
- Hold1
- Sell1
- Strong sell0
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
PETS Revenue — quarterly 41.02M
PETS Net income — quarterly -6.14M
PETS EPS — quarterly -0.28
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 6, 2024 | Sep 1, 2024 | -0.06 | 0.11 | +0.17 | +283.33% |
| Aug 6, 2024 | Jun 1, 2024 | -0.12 | 0.18 | +0.30 | +250.00% |
| Jun 11, 2024 | Mar 1, 2024 | 0.00 | -0.25 | — | — |
| Oct 30, 2023 | Sep 1, 2023 | 0.18 | 0.00 | — | — |
| Jul 31, 2023 | Jun 1, 2023 | 0.09 | 0.00 | — | — |
| May 22, 2023 | Mar 1, 2023 | 0.15 | 0.04 | -0.11 | -73.33% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 7, 2024 | Lake Street | down | Buy | Hold |
| Jun 12, 2024 | Lake Street | main | Buy | Buy |
| Jun 12, 2024 | Morgan Stanley | main | Underweight | Underweight |
| Nov 16, 2023 | Morgan Stanley | main | Underweight | Underweight |
| Oct 31, 2023 | Morgan Stanley | main | Underweight | Underweight |
| Oct 19, 2023 | Morgan Stanley | main | Underweight | Underweight |
About PetMed Express, Inc.
PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- Country
- United States
- Website
- 1800petmeds.com
News
- PetMed Express, Inc. to Report Second Quarter Fiscal Year 2027 Financial Results on Tuesday, November 10, 2026
- PetMeds Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $1.4
- PetMeds Enhances Board of Directors with Appointment of Tamar Elkeles as New Independent Director
- PetMeds Appoints Jeff Willard as CEO & President and Announces Board Leadership Transition
- PetMeds Appoints Andrew Parry as Chief Technology Officer
- Head-To-Head Contrast: PetMed Express (NASDAQ:PETS) versus Carvana (NYSE:CVNA)
- 12 Consumer Discretionary Stocks Moving In Monday's After-Market Session
- PetMed Express Q1 Earnings Miss Estimates, Sales Decline Y/Y
- PetMed (PETS) Reports Q1 Loss, Misses Revenue Estimates
Your note
Sign in to keep a note on PETS — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CAMPBELL LESLIE C.G | Director | Purchase | Dec 4, 2024 | 0 |
| CAMPOS SANDRA YVETTE | Chief Executive Officer | Stock Award(Grant) | Apr 28, 2024 | 492,215 |
| CHAMBERS CHRISTINE | Chief Financial Officer | Stock Award(Grant) | May 15, 2024 | 106,488 |
| D'ELIA ROBYN M | Chief Financial Officer | Stock Award(Grant) | Sep 26, 2024 | 250,000 |
| FULGONI GIAN M | Director | Stock Award(Grant) | Aug 7, 2024 | 124,510 |
| MENNEN JUSTIN L. | Director | Stock Award(Grant) | Aug 7, 2024 | 8,873 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Renaissance Technologies, LLC | 6.31% | 1,303,269 | 6.32M | Sep 29, 2024 |
| Hotchkis & Wiley Capital Management, LLC | 5.28% | 1,090,703 | 5.29M | Sep 29, 2024 |
| Vanguard Group Inc | 5.23% | 1,080,275 | 5.24M | Sep 29, 2024 |
| Federated Hermes, Inc. | 2.93% | 606,420 | 2.94M | Sep 29, 2024 |
| Blackrock Inc. | 2.73% | 564,458 | 2.74M | Sep 29, 2024 |
| Oaktop Capital Management II, L.P. | 2.11% | 435,844 | 2.11M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.10% | 640,080 | 3.10M | Sep 29, 2024 |
| Federated Hermes MDT Small Cap Core Fund | 2.66% | 550,634 | 2.67M | Jul 30, 2024 |
| Hotchkis and Wiley Small Cap Diversified Value Fund | 1.64% | 338,500 | 1.64M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 1.49% | 308,394 | 1.50M | Sep 29, 2024 |
| Principal Small Cap Value Fd II | 1.29% | 266,783 | 1.29M | Jul 30, 2024 |
| Schwab Strategic Tr-Schwab Fundamental U.S. Small Company Index ETF | 1.16% | 239,287 | 1.16M | Aug 30, 2024 |